choosing treatment regimens in patients with triple-negative breast cancer
Published 6 years ago • 438 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
1:10
comparing 3 types of targeted therapies for triple-negative breast cancer
-
3:12
triple-negative breast cancer: selecting chemotherapy
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
4:52
treatment strategies for triple-negative breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
5:38
transcode therapeutics begins dosing patients in phase 1 trial for metastatic cancer therapy
-
1:08
neoadjuvant durvalumab shows benefit in triple-negative breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
1:38
treatments under investigation for metastatic tnbc
-
3:50
clinical approach to triple-negative breast cancer
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
0:41
recent advances in targeted therapies for tnbc
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer